Article in Infection and immunity, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
4 citing papers in PubMed, 5 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
7 authors at 2 institutions in 1 country.
Matthew Henkel *Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Justin A Dutta *Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Jessica PartykaDivision of Pediatric Infectious Diseases, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Taylor EddensDivision of Pediatric Infectious Diseases, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Raphael HirschDepartment of Pediatrics, University of California at San Francisco School of Medicine, San Francisco, California, USA.
Jay K KollsUPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Brian T CampfieldDivision of Pediatric Infectious Diseases, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA brian.campfield@chp.edu.ORCID 0000-0002-5380-9837
University of Pittsburgh · USUniversity of California, San Francisco · US
Funding
Training in CD4 T-cell Lung ImmunityR35HL139930 · NHLBI · TULANE UNIVERSITY OF LOUISIANA · PI KOLLS, JAY K · 2018 to 2024
$6.3M
PITTSBURGH PEDIATRIC RHEUMATOLOGY TRAINING GRANTT32AR052282 · NIAMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KOLLS, JAY K · 2005 to 2014
$1.8M
Role of FSTL-1 in ArthritisR01AI073556 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HIRSCH, RAPHAEL · 2008 to 2011
$1.6M
A Critical Role for Follistatin-like Protein-1 in Lung HomeostasisK08HL128809 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CAMPFIELD, BRIAN T · 2015 to 2019
$675k
Antigen discovery and validation in Pneumocystis pneumoniaF30AI114146 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI EDDENS, TAYLOR JOHN · 2014 to 2017
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Regulation of Pulmonary Bacterial Immunity by Follistatin-Like Protein 1. · full record | OpenQuestion